Reports

Research Resources' Weekly/Friday Newsletter, the R2eport: 

 

R2eport 08/17/18R2eport 08/10/18R2eport 08/03/18R2eport 07/27/18R2eport 07/20/18R2eport 07/13/18R2eport 07/06/18R2eport 06/29/18R2eport 06/22/18;  R2eport 06/15/18R2eport 06/08/18R2eport 06/01/18R2eport 05/25/18R2eport 05/18/18R2eport 05/11/18R2eport 05/04/18R2eport 04/27/18R2eport 04/20/18R2eport 04/13/18R2eport 04/06/18R2eport 03/30/18R2eport 03/23/18R2eport 03/16/18R2eport 03/09/18R2eport 03/02/18R2eport 02/23/18R2eport 02/16/18R2eport 02/09/18R2eport 02/02/18R2eport 01/26/18R2eport 01/19/18R2eport 01/12/18R2eport 01/05/18R2eport 12/29/17 [distributed a day early, due to the holiday]; R2eport 12/22/17R2eport 12/15/17R2eport 12/08/17R2eport 12/01/17; due to the Thanksgiving Holiday, R2 did not publish a newsletter on 11/24/17; R2eport 11/17/17R2eport 11/10/17R2eport 11/03/17R2eport 10/27/17R2eoprt 10/20/17R2eport 10/13/17R2eport 10/06/17R2eport 09/29/17R2eport 09/22/17R2eport 09/15/17R2eport 09/08/17R2eport 09/01/17R2eport 08/25/17R2eport 08/18/17R2eport 08/11/17R2eport 08/04/17R2eport 07/28/17R2eport 07/21/17R2eport 07/14/17R2eport 07/07/17R2eport 06/30/17R2eport 06/23/17R2eport 06/16/17R2eport 06/09/17R2eport 06/02/17R2eport 05/26/17R2eport 05/19/17R2eport 05/12/17R2eport 05/05/17R2eport 04/28/17R2eport 04/21/17R2eport 04/14/17R2eport 04/07/17R2eport 03/31/17R2eport 03/24/17R2eport 03/17/17R2eport 03/10/17R2eport 03/03/17R2eport 02/24/17R2eport 02/17/17R2eport 02/10/17R2eport 02/03/17R2eport 01/27/17R2eport 01/20/17R2eport 01/13/17R2eport 01/06/17R2eport 12/30/16R2eport 12/23/16R2eport 12/16/16R2eport 12/09/16R2eport 12/02/16; due to the Thanksgiving Holiday, R2 did not publish a newsletter on 11/25/16; R2eport 11/18/16R2eport 11/11/16R2eport 11/04/16R2eport 10/28/16R2eport 10/21/16R2eport 10/14/16R2eport 10/07/16R2eport 09/30/16R2eport 09/23/16R2eport 09/16/16R2eport 09/09/16R2eport 09/02/16R2eport 08/26/16R2eport 08/19/16R2eport 08/12/16R2eport 08/05/16R2eport 07/29/16R2eport 07/22/16R2eport 07/15/16R2eport 07/08/16R2eport 07/01/16R2eport 06/24/16R2eport 06/17/16R2eport 06/10/16R2eport 06/03/16R2eport 05/27/16R2eport 05/20/16R2eport 05/13/16R2eport 05/06/16R2eport 04/29/16R2eport 04/22/16R2eport 04/15/16R2eport 04/08/16R2eport 04/01/16R2eport 03/25/16R2eport 03/18/16R2eport 03/11/16R2eport 03/04/16R2eport 02/26/16R2eport 02/19/16R2eport 02/12/16R2eport 02/05/16R2eport 01/29/16R2eport 01/22/16R2eport 01/15/16R2eport 01/08/16R2eport 12/30/15R2eport 12/18/15R2eport 12/11/15R2eport 12/04/15R2eport 11/20/15R2eport 11/13/15R2eport 11/06/15R2eport 10/30/15R2eport 10/23/15R2eport 10/19/15R2eport 10/16/15R2eport 10/09/15R2eport 10/02/15R2eport 09/25/15R2eport 09/18/15R2eport 09/11/15R2eport 09/04/15R2eport 08/28/15R2eport 08/21/15R2eport 08/14/15R2eport 08/07/15R2eport 07/31/15R2eport 07/24/15R2eport 07/14/15R2eport 07/03/15R2eport 06/26/15R2eport 06/19/15R2eport 06/12/15R2eport 06/05/15R2eport 05/29/15R2eport 05/22/15R2eport 05/15/15R2eport 05/08/15R2eport 05/01/15R2eport 04/24/15R2eport 04/17/15R2eport 04/10/15R2eport 04/03/15R2eport 03/27/15R2eport 03/20/15R2eport 03/13/15R2eport 03/06/15R2eport 02/27/15R2eport 02/20/15R2eport 02/13/15R2eport 02/06/15R2eport 01/30/15R2eport 01/23/15R2eport 01/16/15R2eport 01/09/15R2eport 12/24/14;

 

NTW Entries in Tabular Format from our R2eport 08/17/18 are listed below:

 

 

New This Week (Tabular)

Category (first appearance)

Title (linked)

Sponsor

Deadline (if multiple, first and last presented)

WEEKLY HIGHLIGHT

DEPARTMENT OF DEFENSE

 

Reminder! FY18 DoD Duchenne Muscular Dystrophy Research Program (DMDRP) Investigator-Initiated Research Award PRE-APPLICATION DEADLINE (08.29.2018) APPROACHING; 12.05.2018 (Application Deadline)

Department of Defense

08/29/2018 (Pre-Proposal); 10/2018 (Invitation to submit); 12/05/2018 (Application)

 

JUST RELEASED! FY18 DoD PH/TBIRP Program Announcements; Department of Defense (DoD) Psychological Health / Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP); Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Development Award (CTRR-CTDA)

Department of Defense

09/24/2018 (Pre-Proposal); 12/17/2018 (Application)

 

JUST RELEASED! FY18 DoD PH/TBIRP Program Announcements; Department of Defense (DoD) Psychological Health / Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP); Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Development Award (CTRR-CTDA)

Department of Defense

09/24/2018 (Pre-Proposal); 12/17/2018 (Application)

 

JUST RELEASED! FY18 DoD PH/TBIRP Program Announcements; Department of Defense (DoD) Psychological Health / Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP). Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Award (CTRR-CTA)

Department of Defense

09/24/2018 (Pre-Proposal); 12/17/2018 (Application)

LIMITED SUBMISSION

FOUNDATION FUNDING

Limited Submission; Johnson & Johnson WiSTEM2D Scholars Award Program; Internal Deadline 08.28.18; Sponsor Deadeline 09.25.18

Johnson & Johnson

08/28/2018 (Internal Deadline); 09/25/2018 (Sponsor Deadline)

RESEARCH SUPPORT SERVICES

Update on Research Support Services, Spring 2018; we are pleased to expand the Research Support Services to also include resubmissions of otherwise eligible R01, P, K, Center and T32 grants (if the services have not yet been utilized)

 

Mailman School

relative to upcoming NIH Grant Submission Deadlines: 5 weeks prior to submission deadline (Inform R2 of intent to utilize services); 4 weeks prior to submission deadline (science draft for external review); 2 weeks prior to submission deadline (submission for editing services)

RESEARCH INITIATIVES IN SCIENCE AND ENGINEERING (RISE)

Research Initiatives in Science and Engineering (RISE)

 

The Office of the Executive Vice President for Research; Columbia University

 

10/08/2018

 

2019 APHA PUBLIC HEALTH FELLOWSHIP IN GOVERNMENT

2019 APHA Public Health Fellowship in Government

 

APHA, American Public Health Association; On behalf of the American Public Health Association

09/04/2018

 

 

The Matsumae International Foundation(MIF); Japan-Short Term Fellowship

The Matsumae International Foundation(MIF)

 

08/31/2018

 

CARDIOVASCULAR

Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required)

National Institute on Aging; National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke

12/17/2018; 12/18/2018 (Expiration)

 

HIV

AIDS

PEPFAR

Ensuring High Quality in Mentor Mother Strategy Implementation: Helping Mothers Eliminate Pediatric HIV in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)

10/15/2018

Center for Global Health/CDC/DHHS

CANCER

Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not Allowed)

National Cancer Institute

 

11/15/2018; 11/16/2018 (Expiration)

 

 

Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required)

National Cancer Institute

 

01/09/2019; 01/10/2019 (Expiration)

 

 

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

National Cancer Institute

 

Standard dates ; Standard AIDS dates ; 09/08/2021 (Expiration)

 

 

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)

National Cancer Institute

 

Standard dates ; Standard AIDS dates ; 09/08/2021 (Expiration)

 

MINORITY HEALTH

HEALTH DISPARITIES

NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37)

 

National Institute on Minority Health and Health Disparities; John E. Fogarty International Center

10/11/2018; 10/12/2018 (Expiration)

DIVERSITY

Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)

National Institute of Mental Health

 

12/06/2018; 04/09/2019; 08/06/2019; 12/06/2019; 04/07/2020; 08/06/2020; 12/07/2020; 04/06/2021; 04/07/2021 (Expiration)

BEHAVIORAL

Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)

 

National Institute of Mental Health

 

11/20/2018; 11/20/2019; 11/20/2020; 11/21/2020 (Expiration)

TRANSLATIONAL

NEUROLOGY

Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection (U01 Clinical Trial Not Allowed)

National Institute of Neurological Disorders and Stroke

 

12/13/2018; 12/14/2018 (Expiration)

 

 

Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection - Coordinating Center (U24 Clinical Trial Not Allowed)

National Institute of Neurological Disorders and Stroke

 

12/13/2018; 12/14/2018 (Expiration)

 

BIG DATA

NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)

 

National Library of Medicine

 

Standard dates ; Standard AIDS dates ; 09/08/2021 (Expiration)

DERMATOLOGY

Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)

National Institute of Arthritis and Musculoskeletal and Skin Diseases

 

10/04/2018; 07/03/2019; 07/04/2019 (Expiration)

MUSKULOSKELETAL

Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)

National Institute of Arthritis and Musculoskeletal and Skin Diseases

 

10/04/2018; 07/03/2019; 07/04/2019 (Expiration)

REACH FOR THE FIRST R01

Reach for the First R01

 

Irving Institute

09/14/2018 (Application); 10/2018 (Workshop)

ARTIFICIAL INTELLIGENCE

Artificial Intelligence Molecular Screen (AIMS) Awards

www.atomwise.com

09/07/2018

 

Register Now for NCATS Day on September 28, 2018; NCATS Day 2018: Engaging Patients and Communities for Smarter Science on September 28, 2018

NCATS

09/28/2018 (Event Date)

SBIR

Small Business Innovation Research (SBIR) Contract

 

National Institutes of Health (NIH); Centers for Disease Control and Prevention (CDC); The National Center for Advancing Translational Sciences (NCATS) at the National Institute of Health

10/22/2018

 

NCATS CTSA Collaborative Funding Available

 

The National Center for Advancing Translational Sciences (NCATS) at NIH

07/15/2016; 11/01/2016; 03/01/2017; 11/01/2017; 11/01/2018; 03/01/2019; 03/02/2019 (Expiration)

ENVIRONMENTAL PROTECTION AGENCY

Practical Methods to Analyze and Treat Emerging Contaminants (PFAS) in Solid Waste, Landfills, Wastewater/Leachates, Soils, and Groundwater to Protect Human Health and the Environment Request For Application (RFA)

EPA

10/02/2018

RESEARCH RESOURCES INFORMATION SESSION

The ABCs of NIH Grants and Columbia Grant Preparation Boot Camp

 

Research Resources

Thursday September 27, 2018 (09/27/2018) from 12:00 PM – 1:30 PM in Hess Student Commons

 

Writing Superior, Clear and Innovative Specific Aims Workshop

 

Research Resources

Tuesday October 16, 2018, 3:30 PM – 5:00 PM; Hess Student Commons; 10/16/2018

ASPPH WEEKLY NEWSLETTER

ASPPH WEEKLY NEWSLETTER, 08/17/18

http://aspph.org

NA

 

STANDARD DUE DATES

 

Standard Due Dates

 

https://grants.nih.gov/grants/how-to-apply-application-guide/due-dates-and-submission-policies/due-dates.htm

 

 

 

NEW THIS WEEK [NTW]

 

Funding opportunities and announcements listed in the “New this Week” section will be moved to the main body of the newsletter in the following weeks. They are presented and hyperlinked (in the posted .pdf version of the newsletter) in the following order:

 

 

WEEKLY HIGHLIGHT; DEPARTMENT OF DEFENSE; LIMITED SUBMISSION; FOUNDATION FUNDING; RESEARCH SUPPORT SERVICES; RESEARCH INITIATIVES IN SCIENCE AND ENGINEERING (RISE); 2019 APHA PUBLIC HEALTH FELLOWSHIP IN GOVERNMENT; CARDIOVASCULAR; HIV; AIDS; PEPFAR; CANCER; MINORITY HEALTH; HEALTH DISPARITIES; DIVERSITY; BEHAVIORAL; TRANSLATIONAL; NEUROLOGY; BIG DATA; DERMATOLOGY; MUSKULOSKELETAL; REACH FOR THE FIRST R01; ARTIFICIAL INTELLIGENCE; SBIR; ENVIRONMENTAL PROTECTION AGENCY; RESEARCH RESOURCES INFORMATION SESSION; ASPPH WEEKLY NEWSLETTER; STANDARD DUE DATES

 

 

 

[NTW] [WEEKLY HIGHLIGHT/DEPARTMENT OF DEFENSE]
Reminder! FY18 DoD Duchenne Muscular Dystrophy Research Program (DMDRP) Investigator-Initiated Research Award PRE-APPLICATION DEADLINE (08.29.2018) APPROACHING; 12.05.2018 (Application Deadline)

Sponsor: Department of Defense

Deadline(s): 08/29/2018 (Pre-Proposal); 10/2018 (Invitation to submit); 12/05/2018 (Application)

Contact: CDMRP Help Desk; 301-682-5507; help@ebrap.org; Extramural Submissions – Grants.gov contact center; 800-518-4726; support@grants.gov

Link(s): http://cdmrp.army.mil/funding/pa/FY18-DMDRP-IIRA.pdf

http://cdmrp.army.mil/funding/pa/FY18-DMDRP-GAI.pdf

http://cdmrp.army.mil/funding/dmdrp

Additional Information: Reminder! FY18 DoD DMDRP PRE-APPLICATION DEADLINE APPROACHING; The goal of the Duchenne Muscular Dystrophy Research Program (DMDRP) is to preserve and improve the function and quality of life and to extend the life span of all individuals with Duchenne. As such, the DMDRP is seeking to better support discovery and development of therapeutics, devices, and other interventions and to promote their rigorous clinical testing.; Deadline: Pre-application (Preproposal) Investigator-Initiated Research Award Due: August 29, 2018 5:00 p.m. Eastern time (ET); Application Due (by invitation): December 5, 2018 11:59 p.m. ET; A detailed description of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcement. The Program Announcement is available electronically for downloading from the Grants [dot] gov website, the CDMRP website http://cdmrp.army.mil/funding/prgdefault.shtml and the electronic Biomedical Research Application Portal (eBRAP) https://eBRAP.org ; Submission is a two-step process requiring both pre-application submission and full application submission.  All pre-applications must be submitted through eBRAP https://eBRAP.org .  Full applications from extramural organizations (non-DoD organizations) must be submitted through Grants.gov http://www.grants.gov .  Intramural DoD organizations may submit full applications to either eBRAP or Grants.gov.  Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov.  For detailed information on the submission process, refer to Section II.D. of the Program Announcement/Funding Opportunity.

 

 

[NTW] [DEPARTMENT OF DEFENSE]
JUST RELEASED! FY18 DoD PH/TBIRP Program Announcements; Department of Defense (DoD) Psychological Health / Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP); Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Development Award (CTRR-CTDA)

Sponsor: Department of Defense

Deadline(s): 09/24/2018 (Pre-Proposal); 12/17/2018 (Application)

Contact: CDMRP Help Desk; 301-682-5507; help@ebrap.org; Extramural Submissions – Grants.gov contact center; 800-518-4726; support@grants.gov

Link(s): http://cdmrp.army.mil/funding/pa/FY18-PHTBI-CTRR-CTDA.pdf

http://cdmrp.army.mil/funding/pa/FY18-PHTBI-CTRR-GAI.pdf

http://cdmrp.army.mil/funding/phtbi

http://cdmrp.army.mil/funding/prgdefault.shtml

Additional Information: JUST RELEASED! FY18 DoD PH/TBIRP Program Announcements; This e-mail is to notify the research community of the recently released Fiscal Year 2018 (FY18) funding opportunities for the Department of Defense (DoD) Psychological Health / Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP). ; [1] Complex Traumatic Brain Injury Rehabilitation Research - Clinical Research Award (CTRR-CRA); [2] Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Award (CTRR-CTA); [3] Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Development Award (CTRR-CTDA); Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website http://www.grants.gov, the CDMRP website http://cdmrp.army.mil/funding/prgdefault.shtml, and the electronic Biomedical Research Application Portal (eBRAP) https://eBRAP.org.; All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website http://cdmrp.army.mil.; Subsequent notifications will be sent when additional funding opportunities are released. A listing of all open CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.; Submission is a two-step process requiring both pre-application submission and full application submission.  All pre-applications must be submitted through eBRAP https://eBRAP.org/.  Full applications from extramural organizations (non-DoD organizations) must be submitted through Grants.gov http://www.grants.gov/.  Intramural DoD organizations may submit full applications to either eBRAP or Grants.gov.  Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov.  For detailed information on the submission process, refer to Section II.D. of the Program Announcement/Funding Opportunity.;  eBRAP is a multifunctional web-based system that allows PIs to submit their pre-applications electronically through a secure connection, to view and edit the content of their pre-applications and full applications, to receive communications from the CDMRP, and to submit documentation during award negotiations and period of performance.  A key feature of eBRAP is the ability of an organization’s representatives and PIs to view and modify the Grants.gov application submissions associated with them.  eBRAP will validate Grants.gov application files against the specific Program Announcement/Funding Opportunity requirements and discrepancies will be noted in an email to the PI and in the Full Application Files tab in eBRAP.  It is the applicant’s responsibility to review all application components for accuracy as well as ensure proper ordering as specified in this Program Announcement/Funding Opportunity. ; DoD PHTBI JPC8 Funding Opportunities; I’m just forwarding these DoD funding opportunities on the Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP).  [brought to our attention by] Stephanie Scott; DoD PHTBI JPC8 Funding Opportunities; Defense Health Program; Department of Defense Psychological Health / Traumatic Brain Injury Research Program; Funding Opportunities for Fiscal Year 2018/2019 (FY18/19); The FY18 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP) to support critical traumatic brain injury (TBI)- and psychological health (PH)-related research and development efforts to benefit Service members, Veterans, and other beneficiaries of the military health system.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate, manages the Defense Health Program’s Research, Development, Test, and Evaluation appropriation.  The U.S. Army Medical Research and Materiel Command (USAMRMC) Congressionally Directed Medical Research Programs (CDMRP) provides execution management support for DHA research program areas, including the Joint Program Committee-8/Clinical and Rehabilitative Medicine Research Program (JPC-8/CRMRP).  The managing agent for this Program Announcement is the CDMRP with strategic oversight from the JPC-8/CRMRP. ; The FY18/19 PH/TBIRP will solicit research applications for the following CTRR Focus Areas: Mechanisms of Recovery following isolated or cumulative TBI(s) in Service member-relevant injuries:  Clinical research in human subjects that measures physiologic responses to cognitive rehabilitation with the intent to better understand how rehabilitation remediates cognitive or sensorimotor deficits, and ultimately to optimize rehabilitation prescription. ; Ecological Assessment:  Investigation of outcome measures focused on military-specific tasks that inform return-to-duty/participation decisions following rehabilitation in patients with TBI.; Cognitive Rehabilitation:  Evaluation of rehabilitation intervention effectiveness in remediating cognitive impairments and functional limitations after TBI.; https://www.grants.gov/web/grants/search-grants.html; A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism is also on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. ; For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PH/TBIRP or other CDMRP-administered programs, please visit the CDMRP website http://cdmrp.army.mil .; Point of Contact: CDMRP Help Desk; 301-682-5507; help@eBRap.org; CTRR – Clinical Trial Development Award (CTRR-CTDA) – Preproposal due September 24, 2018; Independent investigators at all academic levels (or equivalent); (*) Supports design and development of the necessary research resources that will serve as a foundation for investigator-initiated clinical trials as described above under CTRR – Clinical Trial Award (CTRR-CTA); (*) Final supporting studies required for approval of Investigational New Drug Applications/Investigational Device Exemptions (IND/IDE-enabling) are allowed.  Other preclinical studies are not allowed.; (*) Clinical trials are not allowed within the period of performance of the CTRR-CTDA.; (*) Must address one or more FY18/19 PH/TBIRP CTRR Focus Areas.; Preproposal is required; application submission is by invitation only.; (*) Maximum funding of $200,000 for total costs (includes direct and indirect costs).; (*) Maximum period of performance is 12 months.

 

 

[NTW] [DEPARTMENT OF DEFENSE]
JUST RELEASED! FY18 DoD PH/TBIRP Program Announcements; Department of Defense (DoD) Psychological Health / Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP); Complex Traumatic Brain Injury Rehabilitation Research - Clinical Research Award (CTRR-CRA)

Sponsor: Department of Defense

Deadline(s): 09/24/2018 (Pre-Proposal); 12/17/2018 (Application)

Contact: CDMRP Help Desk; 301-682-5507; help@ebrap.org; Extramural Submissions – Grants.gov contact center; 800-518-4726; support@grants.gov

Link(s): http://cdmrp.army.mil/funding/pa/FY18-PHTBI-CTRR-CRA.pdf

http://cdmrp.army.mil/funding/pa/FY18-PHTBI-CTRR-GAI.pdf

http://cdmrp.army.mil/funding/phtbi

http://cdmrp.army.mil/funding/prgdefault.shtml

Additional Information: JUST RELEASED! FY18 DoD PH/TBIRP Program Announcements; This e-mail is to notify the research community of the recently released Fiscal Year 2018 (FY18) funding opportunities for the Department of Defense (DoD) Psychological Health / Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP). ; [1] Complex Traumatic Brain Injury Rehabilitation Research - Clinical Research Award (CTRR-CRA); [2] Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Award (CTRR-CTA); [3] Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Development Award (CTRR-CTDA); Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website http://www.grants.gov, the CDMRP website http://cdmrp.army.mil/funding/prgdefault.shtml, and the electronic Biomedical Research Application Portal (eBRAP) https://eBRAP.org.; All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website http://cdmrp.army.mil.; Subsequent notifications will be sent when additional funding opportunities are released. A listing of all open CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.; Submission is a two-step process requiring both pre-application submission and full application submission.  All pre-applications must be submitted through eBRAP https://eBRAP.org/.  Full applications from extramural organizations (non-DoD organizations) must be submitted through Grants.gov http://www.grants.gov/.  Intramural DoD organizations may submit full applications to either eBRAP or Grants.gov.  Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov.  For detailed information on the submission process, refer to Section II.D. of the Program Announcement/Funding Opportunity.;  eBRAP is a multifunctional web-based system that allows PIs to submit their pre-applications electronically through a secure connection, to view and edit the content of their pre-applications and full applications, to receive communications from the CDMRP, and to submit documentation during award negotiations and period of performance.  A key feature of eBRAP is the ability of an organization’s representatives and PIs to view and modify the Grants.gov application submissions associated with them.  eBRAP will validate Grants.gov application files against the specific Program Announcement/Funding Opportunity requirements and discrepancies will be noted in an email to the PI and in the Full Application Files tab in eBRAP.  It is the applicant’s responsibility to review all application components for accuracy as well as ensure proper ordering as specified in this Program Announcement/Funding Opportunity.;  DoD PHTBI JPC8 Funding Opportunities; I’m just forwarding these DoD funding opportunities on the Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP).  [brought to our attention by] Stephanie Scott; DoD PHTBI JPC8 Funding Opportunities; Defense Health Program; Department of Defense Psychological Health/Traumatic Brain Injury Research Program; Funding Opportunities for Fiscal Year 2018/2019 (FY18/19); The FY18 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP) to support critical traumatic brain injury (TBI)- and psychological health (PH)-related research and development efforts to benefit Service members, Veterans, and other beneficiaries of the military health system.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate, manages the Defense Health Program’s Research, Development, Test, and Evaluation appropriation.  The U.S. Army Medical Research and Materiel Command (USAMRMC) Congressionally Directed Medical Research Programs (CDMRP) provides execution management support for DHA research program areas, including the Joint Program Committee-8/Clinical and Rehabilitative Medicine Research Program (JPC-8/CRMRP).  The managing agent for this Program Announcement is the CDMRP with strategic oversight from the JPC-8/CRMRP. ; The FY18/19 PH/TBIRP will solicit research applications for the following CTRR Focus Areas: Mechanisms of Recovery following isolated or cumulative TBI(s) in Service member-relevant injuries:  Clinical research in human subjects that measures physiologic responses to cognitive rehabilitation with the intent to better understand how rehabilitation remediates cognitive or sensorimotor deficits, and ultimately to optimize rehabilitation prescription. ; Ecological Assessment:  Investigation of outcome measures focused on military-specific tasks that inform return-to-duty/participation decisions following rehabilitation in patients with TBI.; Cognitive Rehabilitation:  Evaluation of rehabilitation intervention effectiveness in remediating cognitive impairments and functional limitations after TBI.; https://www.grants.gov/web/grants/search-grants.html; A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism is also on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. ; For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PH/TBIRP or other CDMRP-administered programs, please visit the CDMRP website http://cdmrp.army.mil  .; Point of Contact: CDMRP Help Desk; 301-682-5507; help@eBRap.org; CTRR – Clinical Research Award (CTRR-CRA) – Preproposal due September 24, 2018; Independent investigators at all academic levels (or equivalent); (*) Supports applied and translational research to advance the development of knowledge and materiel products for rehabilitation and restoration of function following TBI.; (*) Supported research can include preclinical studies using human subjects or samples and observational or mechanistic clinical research studies.; (*) Clinical trials are not allowed.; (*) Preclinical research using animals is not allowed.; (*) Must address one or more FY18/19 PH/TBIRP CTRR Focus Areas.; Preproposal is required; application submission is by invitation only.; (*) Maximum funding of $2.0M for total costs (includes direct and indirect costs).; (*) Maximum period of performance is years.

 

 

[NTW] [DEPARTMENT OF DEFENSE]
JUST RELEASED! FY18 DoD PH/TBIRP Program Announcements; Department of Defense (DoD) Psychological Health / Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP). Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Award (CTRR-CTA)

Sponsor: Department of Defense

Deadline(s): 09/24/2018 (Pre-Proposal); 12/17/2018 (Application)

Contact: CDMRP Help Desk; 301-682-5507; help@ebrap.org; Extramural Submissions – Grants.gov contact center; 800-518-4726; support@grants.gov

Link(s): http://cdmrp.army.mil/funding/pa/FY18-PHTBI-CTRR-CTA.pdf

http://cdmrp.army.mil/funding/pa/FY18-PHTBI-CTRR-GAI.pdf

http://cdmrp.army.mil/funding/phtbi

http://cdmrp.army.mil/funding/prgdefault.shtml

Additional Information: JUST RELEASED! FY18 DoD PH/TBIRP Program Announcements; This e-mail is to notify the research community of the recently released Fiscal Year 2018 (FY18) funding opportunities for the Department of Defense (DoD) Psychological Health / Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP). ; [1] Complex Traumatic Brain Injury Rehabilitation Research - Clinical Research Award (CTRR-CRA); [2] Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Award (CTRR-CTA); [3] Complex Traumatic Brain Injury Rehabilitation Research - Clinical Trial Development Award (CTRR-CTDA); Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website http://www.grants.gov, the CDMRP website http://cdmrp.army.mil/funding/prgdefault.shtml, and the electronic Biomedical Research Application Portal (eBRAP) https://eBRAP.org.; All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website http://cdmrp.army.mil.; Subsequent notifications will be sent when additional funding opportunities are released. A listing of all open CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.; Submission is a two-step process requiring both pre-application submission and full application submission.  All pre-applications must be submitted through eBRAP https://eBRAP.org/.  Full applications from extramural organizations (non-DoD organizations) must be submitted through Grants.gov http://www.grants.gov/.  Intramural DoD organizations may submit full applications to either eBRAP or Grants.gov.  Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov.  For detailed information on the submission process, refer to Section II.D. of the Program Announcement/Funding Opportunity.;  eBRAP is a multifunctional web-based system that allows PIs to submit their pre-applications electronically through a secure connection, to view and edit the content of their pre-applications and full applications, to receive communications from the CDMRP, and to submit documentation during award negotiations and period of performance.  A key feature of eBRAP is the ability of an organization’s representatives and PIs to view and modify the Grants.gov application submissions associated with them.  eBRAP will validate Grants.gov application files against the specific Program Announcement/Funding Opportunity requirements and discrepancies will be noted in an email to the PI and in the Full Application Files tab in eBRAP.  It is the applicant’s responsibility to review all application components for accuracy as well as ensure proper ordering as specified in this Program Announcement/Funding Opportunity. ; DoD PHTBI JPC8 Funding Opportunities; I’m just forwarding these DoD funding opportunities on the Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP).  [brought to our attention by] Stephanie Scott; DoD PHTBI JPC8 Funding Opportunities; Defense Health Program; Department of Defense Psychological Health/Traumatic Brain Injury Research Program; Funding Opportunities for Fiscal Year 2018/2019 (FY18/19); The FY18 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP) to support critical traumatic brain injury (TBI)- and psychological health (PH)-related research and development efforts to benefit Service members, Veterans, and other beneficiaries of the military health system.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate, manages the Defense Health Program’s Research, Development, Test, and Evaluation appropriation.  The U.S. Army Medical Research and Materiel Command (USAMRMC) Congressionally Directed Medical Research Programs (CDMRP) provides execution management support for DHA research program areas, including the Joint Program Committee-8/Clinical and Rehabilitative Medicine Research Program (JPC-8/CRMRP).  The managing agent for this Program Announcement is the CDMRP with strategic oversight from the JPC-8/CRMRP. ; The FY18/19 PH/TBIRP will solicit research applications for the following CTRR Focus Areas: Mechanisms of Recovery following isolated or cumulative TBI(s) in Service member-relevant injuries:  Clinical research in human subjects that measures physiologic responses to cognitive rehabilitation with the intent to better understand how rehabilitation remediates cognitive or sensorimotor deficits, and ultimately to optimize rehabilitation prescription. ; Ecological Assessment:  Investigation of outcome measures focused on military-specific tasks that inform return-to-duty/participation decisions following rehabilitation in patients with TBI.; Cognitive Rehabilitation:  Evaluation of rehabilitation intervention effectiveness in remediating cognitive impairments and functional limitations after TBI.; https://www.grants.gov/web/grants/search-grants.html; A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism is also on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. ; For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PH/TBIRP or other CDMRP-administered programs, please visit the CDMRP website http://cdmrp.army.mil .; Point of Contact: CDMRP Help Desk; 301-682-5507; help@eBRap.org ; CTRR – Clinical Trial Award (CTRR-CTA) – Preproposal due September 24, 2018; Independent investigators at all academic levels (or equivalent); (*) Supports small, single-site, Phase I clinical trials to advance the development of knowledge and materiel products for rehabilitation and restoration of function following TBI in Service members, Veterans, and other individuals.; (*) Interventions should be limited, existing, and manualized.  Studies may include seeking to optimize dosing in existing interventions.; (*) Preclinical studies are not allowed.; (*) Must address one or more FY18/19 PH/TBIRP CTRR Focus Areas.; Preproposal is required; application submission is by invitation only.; (*) Maximum funding of $2.0M for total costs (includes direct and indirect costs).; (*) Maximum period of performance is 3 years.

 

 

 

[NTW] [LIMITED SUBMISSION/FOUNDATION FUNDING]
Limited Submission; Johnson & Johnson WiSTEM2D Scholars Award Program; Internal Deadline 08.28.18; Sponsor Deadeline 09.25.18

Sponsor: Johnson & Johnson

Deadline(s): 08/28/2018 (Internal Deadline); 09/25/2018 (Sponsor Deadline)

Contact: Please combine all six parts of the internal proposal in a single PDF file and email to limitedsubmissions@columbia.edu by 9:00 a.m. on Tuesday, August 28.  “WiSTEM2D” should appear in the subject line.; For additional information or questions, please contact limitedsubmissions@columbia.edu.; Program URL:

Link(s): https://www.jnj.com/wistem2d (Program URL provided for references, this is a limited submission, internally vetted opportunity)

Additional Information: Johnson & Johnson WiSTEM2D Scholars Award Program; Limited Submission; Johnson & Johnson WiSTEM2D Scholars Award Program; Internal Proposal Deadline – 9:00 a.m. on Tuesday, August 28; What - The J&J WiSTEM2D Scholars Award Program will help develop female leaders and support innovation in the STEM2D disciplines (Science, Technology, Engineering, Math, Manufacturing, Design) by funding one woman working as a tenure-track assistant professor in each of the STEM2D disciplines. The Scholars Award is a 3-year award in the gross amount of $150,000, paid in three (3) installments of US $50,000 per year. Award recipients will also gain access mentorship from STEM2D professionals.; Important: Due to the J&J terms and conditions, only non-confidential information should be included in proposals submitted to this program.; Program Emphasis - The eligible STEM²D disciplines are: Science, Technology, Engineering, Math, Manufacturing, and Design. J&J provides the following definitions for the eligible disciplines.; (*) Science Observing, studying and experimenting in an effort to better understand the natural world and how it works.; (*) Technology Science or knowledge put to practical use to solve problems, invent useful tools, envision new possibilities or establish meaningful connections between people and the world that surrounds them.; (*) Engineering The practical application of science and math skills to everyday life. ; (*) Mathematics Quantitative framework (numbers, quantities, shapes, abstract principles and problem solving) for describing the world.; (*) Manufacturing Creating something from raw materials by hand or by machinery. ; (*) Design A collaborative activity that results in better human experiences by uncovering unmet needs and championing meaningful relationships through user-friendly products, environments and systems.; Who - Eligibility is limited to: (*) Female, tenure-track assistant professors working in Science, Technology, Engineering, Math, Manufacturing, or Design with following degrees per field:  (**) Science – MD, PhD; (**) Technology – PhD; (*)Engineering – PhD; (**) Math – MS, PhD; (**) Manufacturing – PhD; (**) Design – MA, MS, MDes, MArch, MLA, MFA, PhD; Institutional Limit - Final Sponsor Proposal: one proposal per discipline; When - Internal deadline – 9:00 a.m. on Tuesday, August 28; Sponsor deadline – September 25; How - The internal proposal must include the following five components: [1] Cover page listing the PI’s name, title, department, and contact information; [2] Letter of Recommendation from the applicant’s department chair; [3] Research Plan, limited to 1,000-words (plus one page of figures/images), describing proposed research. ; [4] CV (three pages, font size 11), including a list of publications,  presentations, abstracts, current financial support already obtained, other folio work, and two references. ; [5] Brief outline of budget for proposed research; Please combine all six parts of the internal proposal in a single PDF file and email to limitedsubmissions@columbia.edu by 9:00 a.m. on Tuesday, August 28.  “WiSTEM2D” should appear in the subject line.; For additional information or questions, please contact limitedsubmissions@columbia.edu.; Program URL: https://www.jnj.com/wistem2d

 

 

 

[NTW] [RESEARCH SUPPORT SERVICES]
Update on Research Support Services, Spring 2018; we are pleased to expand the Research Support Services to also include resubmissions of otherwise eligible R01, P, K, Center and T32 grants (if the services have not yet been utilized)

Sponsor: Mailman School                                                                                          

Deadline(s): relative to upcoming NIH Grant Submission Deadlines: 5 weeks prior to submission deadline (Inform R2 of intent to utilize services); 4 weeks prior to submission deadline (science draft for external review); 2 weeks prior to submission deadline (submission for editing services)

Contact: Pam Factor-Litvak (Associate Dean, Research Resources, and Professor of Epidemiology) prf1@columbia.edu; Craig Kandell (Project Coordinator, Research Resources) ckk7@columbia.edu  

Link(s): https://r2eport.files.wordpress.com/2015/05/updateofgrantsupportservicesspring2018gpdf.pdf

Additional Information:

 

Dear Mailman School faculty,

 

I want to give you an update on Research Support Services—the School’s new program for pre-submission external review and final editing. As Dean Fried wrote in October, the program is geared “to support faculty in preparing grant applications with the highest chance of success.”

 

I’m happy to report that those using the services this fall have found them valuable. Katherine Keyes in Epidemiology spoke enthusiastically at the recent Assembly: “It was a great experience. I got to focus on the science without having to deal with any of the administrative aspects. I got really good feedback. I will be using these services again.”

 

In my estimation, all the grants were greatly improved by these services. Of course, the ultimate test is how they are scored and funded. As soon I have that information, I will share it with you.

 

I encourage everyone to take advantage of Research Support Services to give your grants a competitive advantage. Please keep in mind the following deadlines:

 

  • 5 weeks prior to submission deadline—Inform Research Resources (via Craig Kandell at ckk7@cumc.columbia.edu) if you plan on using Research Support Services with information about they the type of grant at least five weeks prior to the grant due date. If you seek external review, please provide the name and contacts of at least three potential reviewers so we can reach out to them in your order of preference.

 

  • 4 weeks prior to submission deadline —Send us your science draft for external review three to four weeks prior to submission. We will forward it to the external reviewer. Generally, they provide feedback within a week.

 

  • 2 weeks prior to submission deadline —For editorial services, send us your manuscript at least 10 days ahead of the deadline. We will make arrangements with the editor. Comments will be returned to Craig and the PI for finalization and submission within a few days.

 

Please keep in mind that it may take you a day or two to incorporate comments and edits. For best results, get in touch with us prior to these deadlines.

 

Research Support Services cover first-time submissions, and we are pleased to expand the service to encompass resubmissions (if the support services have not been utilized for the grant) of R01, P, K, Center, T32, or other complex NIH proposals by full-time faculty with primary appointments in the School. I am available to provide feedback for grants that utilize this service and also for other grant types (such as R21s) that are ineligible for the services.

 

If you have any questions about your eligibility or the above process, please visit Research Resources online or contact me at prf1@columbia.edu.

 

Best wishes,

Pam Factor-Litvak

 

 

[NTW] [RESEARCH INITIATIVES IN SCIENCE AND ENGINEERING (RISE)]
Research Initiatives in Science and Engineering (RISE)

Sponsor: The Office of the Executive Vice President for Research; Columbia University

Deadline(s): 10/08/2018

Contact: rise@columbia.edu ; (212) 854-7836

Link(s): https://research.columbia.edu/content/rise

Additional Information: Save the Date - 2019 RISE Application Window (Sept 5 - Oct 8); Dear Colleagues, I am pleased to announce that the application window for the 2019 Research Initiatives in Science and Engineering (RISE) competition will be from Wednesday, September 5th – Monday, October 8th, 2018.; The RISE program awards seed monies to support innovative, interdisciplinary, high-risk, and potentially high-impact research collaborations that are not ready to receive funding through conventional sources. All Columbia-employed researchers eligible to serve as Principal Investigators may apply, albeit with five important restrictions and recommendations: (*) PIs and Co-PIs currently funded by the RISE program may not submit applications; (*) Applications must be fully collaborative, and must include at least two Lead PIs. Applications from only one PI will not be accepted; (*) At least one of the PIs must be a researcher from a scientific, engineering, and/or biomedical discipline; (*) Applications from PIs that span two or more schools are strongly encouraged; (*) Applications from PIs that have never previously collaborated are encouraged.; I encourage you to begin discussions with potential collaborators, and to consider submitting an application for the RISE competition and help build the diversity of Columbia’s research enterprise.; For more information pertaining to the RISE program, including a list of Frequently Asked Questions and past awarded teams, please visit the website at www.columbia.edu/rise. Direct questions by email to rise@columbia.edu or call 212-854-7836.; Sincerely, G. Michael Purdy, PhD; Executive Vice President for Research; Columbia University in the City of New York

 

 

[NTW] [2019 APHA PUBLIC HEALTH FELLOWSHIP IN GOVERNMENT]
2019 APHA Public Health Fellowship in Government

Sponsor: APHA, American Public Health Association; On behalf of the American Public Health Association

Deadline(s): 09/04/2018

Contact: aphafellowship@apha.org

Link(s): https://www.apha.org/fellowship

https://www.apha.org/-/media/files/pdf/fellowship/application_form.ashx?la=en&hash=678341A55C004E43B1173AE9E7C11341B5515DB5

Additional Information: Public Health Fellowship in Government; applications due Deadline is Sept. 4, 6:00 p.m. ET; APHA, American Public Health Association; On behalf of the American Public Health Association, I am thrilled to announce the call for applications for the 2019 APHA Public Health Fellowship in Government. This is the 10th year APHA is offering this fellowship, which previous fellows have described as an “amazing,” “phenomenal” and “life altering” experience. The fellowship provides a unique learning opportunity and demonstrates the value and need for basing policy on sound science.; Candidates must have strong public health credentials and be able to spend one year in Washington, D.C.  The fellow will have the option of working in the House or Senate on legislative and policy issues such as creating healthy communities, improving health equity, addressing environmental health concerns, population health or the social determinants of health.; Training for the fellowship will begin in January 2019 so you must be able to move to the Washington, D.C., area in January. Throughout the year, the fellow will gain a practical knowledge of government and how the public policy process works.; Fellowship candidates must: [1] be an APHA member; [2] have a graduate degree in public health or a related discipline; [3] have at least five years’ experience as a public health professional beyond graduate or medical training (internships, graduate assistantships and residencies do not count); [4] be a citizen of the U.S. or its territories or have permanent residence status in the U.S.; and [5] not be a federal employee. ; Candidates who do not meet all of the above criteria will not be considered.; Additional information, including the application form and brief articles from the previous fellows, is available on APHA’s website. The completed application, CV and three letters of recommendation are due to APHA by 6 p.m. EDT on Sept. 4, 2018.; Please forward this email to anyone you believe may be eligible and interested. For more information, feel free to contact us at aphafellowship@apha.org or 202-777-2510.; Sincerely, Susan L. Polan, PhD; Associate Executive Director, Public Affairs and Advocacy; This fellowship is sponsored by an unrestricted grant from the Aetna Foundation.


 

 

[NTW] [FOUNDATION FUNDING]
The Matsumae International Foundation(MIF); Japan-Short Term Fellowship

Sponsor: The Matsumae International Foundation(MIF)

Deadline(s): 08/31/2018

Contact: The Matsumae International Foundation(MIF); 4-14-46, Kamiogi; Suginami-ku; Tokyo 167-0043 JAPAN; TEL: +81-3-3301-7600; FAX: +81-3-3301-7601; E-mail: contact@mif-japan.org

Link(s): http://www.mif-japan.org/fellowship/announcement/?hl=en

Additional Information: Short-Term Research Fellowships in Japan by Matsumae International Foundation; Dear Dr. ; A posting soliciting applications for Matsumae International Foundation funded Short-Term Research Fellowships (3-6 months in Japan). The foundation will take care of travel, accommodation, and stipend for your living expenses. Last year, the success rate for applicants from North America was 100%. Twenty applicants will be accepted. We appreciate if you can refer your fellows/students/ junior faculty who may be interested in this program. [brought to our attention by] Trialect [who] can also help connect you with the faculty in Japan, if you are interested in applying, for invitation letters, just email us at Support@trialect.com. Application Process : Apply Here;

 

 

[NTW] [CARDIOVASCULAR]
Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required)

Sponsor: National Institute on Aging; National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke

Deadline(s): 12/17/2018; 12/18/2018 (Expiration)

Contact: Scientific/Research Contact(s); Sergei Romashkan, MD, Ph.D.; National Institute on Aging (NIA); Telephone: 301-435-3047; Email: romashks@nia.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-020.html

 

 

[NTW] [HIV/AIDS/PEPFAR]
Ensuring High Quality in Mentor Mother Strategy Implementation: Helping Mothers Eliminate Pediatric HIV in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)

Sponsor: Center for Global Health/CDC/DHHS

Deadline(s): 10/15/2018

Contact: Jessica Greenberg Cowan, Project Officer; 258843133373; lvp6@cdc.gov

Link(s): https://www.grants.gov/web/grants/view-opportunity.html?oppId=306340

https://spin.infoedglobal.com/Program/Detail/076946

Additional Information: Center for Global Health (CGH) invites applications to fully scale the recently revised Mentor Mother Strategy, which formalizes a system of peer based case management for HIV positive pregnant and breastfeeding women (PBFW). The recipient(s) will provide technical assistance to the national MOH prevention of mother to child transmission (PMTCT) program, provincial health authorities, and PEPFAR partners as they implement peer based psychosocial support and case management for PBFW, HIV exposed infants, and newly diagnosed HIV positive children under 5 years of age. The recipient(s) will directly support implementation of the mentor mother strategy at a number of demonstration sites in provinces and districts with historically high levels of vertical transmission, including districts in Nampula and Zambezia provinces. As such, implementation will be at national, provincial, district, and sub-district levels. A total of approximately $5.0 million is available in FY2019.

 

 

 

[NTW] [LIMITED COMPETITION/AIDS/CANCER]
Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not Allowed)

Sponsor: National Cancer Institute

Deadline(s): 11/15/2018; 11/16/2018 (Expiration)

Contact: Scientific/Research Contact(s); Rebecca Liddell Huppi, Ph.D.; National Cancer Institute (NCI); Telephone: 240-781-3324; Email: liddellr@exchange.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-012.html

 

 

[NTW] [CANCER]
Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required)

Sponsor: National Cancer Institute

Deadline(s): 01/09/2019; 01/10/2019 (Expiration)

Contact: Scientific/Research Contact(s); Nonniekaye Shelburne, M.S., C.R.N.P., A.O.C.N.; National Cancer Institute (NCI); Telephone: 240-276-6897; Email: nshelburne@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-017.html

 

 

[NTW] [CANCER]
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

Sponsor: National Cancer Institute

Deadline(s): Standard dates ; Standard AIDS dates ; 09/08/2021 (Expiration)

Contact: Scientific/Research Contact(s); Frank M. Perna, Ed.D., Ph.D.; National Cancer Institute (NCI)
Telephone: 240-276-6782; Email: pernafm@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-18-892.html

 

 

 

[NTW] [CANCER]
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)

Sponsor: National Cancer Institute

Deadline(s): Standard dates ; Standard AIDS dates ; 09/08/2021 (Expiration)

Contact: Scientific/Research Contact(s); Frank M. Perna, Ed.D., Ph.D.; National Cancer Institute (NCI)
Telephone: 240-276-6782; Email: pernafm@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-18-893.html

 

 

[NTW] [MINORITY HEALTH/HEALTH DISPARITIES]
NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37)

Sponsor: National Institute on Minority Health and Health Disparities; John E. Fogarty International Center

Deadline(s): 10/11/2018; 10/12/2018 (Expiration)

Contact: Scientific/Research Contact(s); Rick Berzon, DrPH, PA; National Institute on Minority Health and Health Disparities (NIMHD); Telephone: 301-594-8949; Email: Rick.Berzon@nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-18-007.html

 

 

 

[NTW] [DIVERSITY]
Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)

Sponsor: National Institute of Mental Health

Deadline(s): 12/06/2018; 04/09/2019; 08/06/2019; 12/06/2019; 04/07/2020; 08/06/2020; 12/07/2020; 04/06/2021; 04/07/2021 (Expiration)

Contact: Scientific/Research Contact(s); Christopher Sarampote, Ph.D.; National Institute of Mental Health (NIMH); Telephone: 301-443-1959; Email: csarampo@mail.nih.gov; Also, please see: 

http://www.nimh.nih.gov/funding/training/contacts-for-research-training-and-career-development-programs.shtml

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-18-894.html

 

 

[NTW] [BEHAVIORAL]
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)

Sponsor: National Institute of Mental Health

Deadline(s): 11/20/2018; 11/20/2019; 11/20/2020; 11/21/2020 (Expiration)

Contact: Scientific/Research Contact(s); Michele Ferrante, Ph.D.; National Institute of Mental Health (NIMH); Telephone: 301-435-6782; Email: michele.ferrante@nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-240.html

 

 

 

[NTW] [TRANSLATIONAL/NEUROLOGY]
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection (U01 Clinical Trial Not Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke

Deadline(s): 12/13/2018; 12/14/2018 (Expiration)

Contact: Scientific/Research Contact(s); Francesca Bosetti, Pharm.D., Ph.D.; National Institute of Neurological Disorders and Stroke (NINDS); Telephone: 301-496-1431; Email: frances@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-033.html

 

 

[NTW] [TRANSLATIONAL/NEUROLOGY]
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection - Coordinating Center (U24 Clinical Trial Not Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke

Deadline(s): 12/13/2018; 12/14/2018 (Expiration)

Contact: Scientific/Research Contact(s); Francesca Bosetti, Pharm.D., Ph.D.; National Institute of Neurological Disorders and Stroke (NINDS); Telephone: 301-496-1431; Email: frances@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-034.html

 

 

 

[NTW] [BIG DATA]
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)

Sponsor: National Library of Medicine

Deadline(s): Standard dates ; Standard AIDS dates ; 09/08/2021 (Expiration)

Contact: Scientific/Research Contact(s); For Clinical and Public Health Informatics: Hua-Chuan Sim, MD
National Library of Medicine (NLM); Telephone: 301-594-4882; Email: simh@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-18-896.html

 

 

[NTW] [DERMATOLOGY]
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases

Deadline(s): 10/04/2018; 07/03/2019; 07/04/2019 (Expiration)

Contact: Scientific/Research Contact(s); Hung Tseng, Ph.D.; National Institute of Arthritis and Musculoskeletal and Skin (NIAMS); Telephone: 301-496-0810; Email: tsengh@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-18-899.html

 

 

 

[NTW] [MUSKULOSKELETAL]
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases

Deadline(s): 10/04/2018; 07/03/2019; 07/04/2019 (Expiration)

Contact: Scientific/Research Contact(s); Amanda Boyce, Ph.D.; National Institute of Arthritis and Musculoskeletal and Skin (NIAMS); Telephone: 301-594-5055; Email: boycea@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PAR-18-900.html

 

 

 

[NTW] [REACH FOR THE FIRST R01]
Reach for the First R01

Sponsor: Irving Institute

Deadline(s): 09/14/2018 (Application); 10/2018 (Workshop)

Contact: For questions about the application process please contact the Irving Institute Education Center at ctsa_edu@cumc.columbia.edu

Link(s): https://www.cognitoforms.com/IrvingInstitute1/Fall18ReachForTheFirstR01Application

http://irvinginstitute.columbia.edu/education/reach_for_r01.html [at Newsletter distribution time, this link has been difficultly accessible; it has worked in the past and is posted for reference]

Additional Information: Reach for the First R01; The Irving Institute is pleased to offer the Reach for the First R01 workshop available twice a year to all promising junior faculty.  Up to six junior investigators are selected for this workshop each term (Fall and Spring), across all departments.  Specifically, successful applicants will receive 5 free hours of biostatistical consulting, access to other Irving Institute Resources, 2 expert pre-reviews on an early draft of their R01 application, and bi-monthly, closely-monitored meetings to ensure structure and timeliness in completing the tasks required to successfully submit a first R01 application.  These resources are intended to enhance, rather than replace, appropriate mentoring.  An applicant without excellent mentoring cannot be seen as competitive for this Workshop.;  To be eligible, the candidate: (*) Must be an Early Stage investigator by the NIH definition; (*) Must be supported/recommended by a senior faculty member (applicants must submit a letter from a senior faculty member who can speak to the applicant's ability to write an independent award and the faculty member's willingness to advise on substantive issues), as well as a letter from their Department Chair.; (*) Must plan for their first submission to be February 5, 2019 (not before, or after). ; (*) must submit their application by 5p EST on Friday, September 14, 2018 to be considered for this cycle; the workshop will start in early October 2018 and will be held on select Fridays from 3:00–4:30p.; (*) Receipt of a “K” award or equivalent is not required to be considered for this award. The application with further instructions and referee forms can be downloaded six to eight weeks prior to the start of each workshop. Please note, more than one junior faculty per Department may apply.; Application deadline: Friday, September 14, 2018; Learn more and submit an application.; For questions about the application process please contact the Irving Institute Education Center at ctsa_edu@cumc.columbia.edu [*]

 

 

 

[NTW] [ARTIFICIAL INTELLIGENCE]
Artificial Intelligence Molecular Screen (AIMS) Awards

Sponsor: www.atomwise.com

Deadline(s): 09/07/2018

Contact: For any questions, please contact Dr. Sara Omlid at sara@atomwise.com

Link(s): http://www.atomwise.com/aims-awards/

Additional Information: Artificial Intelligence Molecular Screen (AIMS) Awards; Request for Proposals: The goal of this program is to broaden the pool of scientists pursuing drug discovery. To advance this goal, Atomwise will award researchers with a customized virtual screen using cutting-edge Artificial Intelligence (AI) technology, free chemical compounds for physical screening, and technical support from medicinal chemists and computational biologists.; Applicants must be a Principal Investigator. Research scientists, graduate students, or postdoctoral researchers can apply for the AIMSTM Award on behalf of or with the approval and support of a Principal Investigator; in these cases, the Applicant with responsibility for the performance of the project must still be the Principal Investigator. The research must be performed at a non-profit university or research institute.; For more information and to view the application, click here. ; Application Deadline: September 7, 2018; Announcement of recipients: October - November 2018; For any questions, please contact Dr. Sara Omlid at sara@atomwise.com [*]

 

 

[NTW] [TRANSLATIONAL]
Register Now for NCATS Day on September 28, 2018; NCATS Day 2018: Engaging Patients and Communities for Smarter Science on September 28, 2018

Sponsor: NCATS

Deadline(s): 09/28/2018 (Event Date)

Contact: NCATSDay@mail.nih.gov

Link(s): https://ncats.nih.gov/ncats-day

http://palladianpartners.cvent.com/events/ncats-day-2018-engaging-patients-and-communities-for-smarter-science/event-summary-942b6051d1784319a18a8f67b93771e4.aspx

https://palladianpartners.cvent.com/events/ncats-day-2018-engaging-patients-and-communities-for-smarter-science/registration-942b6051d1784319a18a8f67b93771e4.aspx

Additional Information: Register Now for NCATS Day on September 28, 2018; Registration is now open for NCATS Day 2018: Engaging Patients and Communities for Smarter Science on September 28, 2018, from 8:30am to 5pm on the NIH main campus in Bethesda, Maryland.; The purpose of the event is to provide a forum to share and reflect upon patient and community needs — as well as best practices in addressing those needs — so that NCATS can best shape its research priorities, programs and initiatives.; Patients and patient advocates, caregivers, community partners, community health engagement professionals, clinical and translational researchers, and others are urged to attend to share and discuss ways to overcome translational research challenges and leverage opportunities through effective patient and community engagement. Participants will learn strategies to broaden participation in research and to incorporate diverse patient and community input into their work.; Admission is complimentary, but space is limited, so be sure to register early.; (*) View the tentative agenda ; (*) Learn more about the event ; (*) Register now

 

 

 

[NTW] [TRANSLATIONAL/SBIR]
Small Business Innovation Research (SBIR) Contract

Sponsor: National Institutes of Health (NIH); Centers for Disease Control and Prevention (CDC); The National Center for Advancing Translational Sciences (NCATS) at the National Institute of Health

Deadline(s): 10/22/2018

Contact: National Center for Advancing Translational Sciences (NCATS); Jeffrey Schmidt; Contracting Officer
NIDA Office of Acquisition; Phone: (301) 402-1488; Email: schmidtjr@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-209.html

https://ncats.nih.gov/smallbusiness

Additional Information:  2019 Contract Solicitation Funding Opportunity Available; The National Center for Advancing Translational Sciences (NCATS) at the National Institute of Health invites small businesses to apply for funding through the 2019 Small Business Innovation Research (SBIR) contract to support small businesses interested in developing innovative health technologies.; The deadline for submitting proposals is October 22, 2018, 5:00pm ET.; NCATS' contract funding topics for 2019 include: (*) Synthetic Technologies for Advancement of Research and Therapeutics (START); (*) Universal Medium/Blood Mimetic for Use in Integrated Organs-on-Chips; (*) Non-PDMS Biocompatible Alternatives for Organs-on-Chips; View the solicitation for more information about contract eligibility, topics, award amounts, submission information and timelines. Applicants are strongly encouraged to read the contract solicitation carefully and must use the electronic Contract Proposal Submission (eCPS) website to submit their proposal. No other method of proposal submission is permitted.; For questions on NCATS SBIR contract topics, please contact NCATS Contracting Officer Jeffrey Schmidt at jeffrey.schmidt@nih.gov

 

 

 

[NTW] [LIMITED COMPETITION/TRANSLATIONAL]
NCATS CTSA Collaborative Funding Available

Sponsor: The National Center for Advancing Translational Sciences (NCATS) at NIH

Deadline(s): 07/15/2016; 11/01/2016; 03/01/2017; 11/01/2017; 11/01/2018; 03/01/2019; 03/02/2019 (Expiration)

Contact: Scientific/Research Contact(s); Erica Rosemond, Ph.D.; National Center for Advancing Translational Sciences (NCATS); Telephone: 301-594-8927; Email: rosemonde@mail.nih.gov

Link(s): https://grants.nih.gov/grants/guide/pa-files/PA-16-328.html

Additional Information: NCATS CTSA Collaborative Funding Available; The National Center for Advancing Translational Sciences (NCATS) at NIH has funding available to explore novel, generalizable approaches to important translational science questions across multiple CTSA sites. Three mechanisms are available – R21, U01 and Admin Supplements. All require collaboration between two/three or more CTSA sites (there are currently 62 nationwide). We strongly encourage any interested and eligible investigator to apply.; We are happy to help interested investigators by assisting you explore partnerships with other CTSA sites, make connections with mentors locally, and providing the required letter of support. Please contact Helena Rincón at hr2016@cumc.columbia.edu or 212-305-0427 for further information.; PA-16-328: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program; Posted 6/14/2016, remaining deadlines Nov 1, 2018, and March 1, 2019; $300K per year, up to two years; https://grants.nih.gov/grants/guide/pa-files/PA-16-328.html ; Accelerating Discoveries Toward Better Health ; irvinginstitute.columbia.edu ; The Irving Institute for Clinical and Translational Research at Columbia University Medical Center is part of the national Clinical and Translational Science Award (CTSA) consortium, and is funded by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Number UL1TR001873. [*]

 

 

 

[NTW] [ENVIRONMENTAL PROTECTION AGENCY (EPA)]
Practical Methods to Analyze and Treat Emerging Contaminants (PFAS) in Solid Waste, Landfills, Wastewater/Leachates, Soils, and Groundwater to Protect Human Health and the Environment Request For Application (RFA)

Sponsor: EPA

Deadline(s): 10/02/2018

Contact: https://www.epa.gov/research-grants/forms/contact-us-about-research-grants

Link(s): https://www.epa.gov/research-grants/practical-methods-analyze-and-treat-emerging-contaminants-pfas-solid-waste-landfills

https://www.epa.gov/research-grants/research-funding-opportunities

Additional Information: Subject: Practical Methods to Analyze and Treat Emerging Contaminants (PFAS) in Solid Waste, Landfills, Wastewater/Leachates, Soils, and Groundwater to Protect Human Health and the Environment Request For Application (RFA) RFA: https://www.epa.gov/research-grants/practical-methods-analyze-and-treat-emerging-contaminants-pfas-solid-waste-landfills ; Funding Opportunities: https://www.epa.gov/research-grants/research-funding-opportunities ; Open Date: Aug. 17, 2018  Close Date: Oct. 2, 2018; Practical Methods to Analyze and Treat Emerging Contaminants (PFAS) in Solid Waste, Landfills, Wastewater/Leachates, Soils, and Groundwater to Protect Human Health and the Environment Request for Application (RFA); Background: Per- and polyfluoroalkyl substances (PFAS) are a large group of approximately 5,000 human-derived chemicals that are used in many consumer products and industrial applications and are known to lead to potential adverse human health effects. PFAS products that people use daily include cookware, food containers and packaging, stain repellant fabrics (clothes, carpets, fabrics, etc.) and others. Industrial applications include food processing, chrome plating, electronics manufacturing, fire-fighting foam, and others. Major contributors to environmental releases include fire training and fire response; industrial production from primary and secondary manufacturing; landfills; and wastewater treatment operations.  Because of the ubiquitous presence, most people may have been exposed to PFAS which can accumulate and stay in the human body for long periods of time. There is evidence that exposure to PFAS can lead to adverse health outcomes in humans. As a result, people exposed to PFAS from different sources over time, the level of PFAS in their bodies may increase to the point where they suffer from adverse health effects such as increase cholesterol level, low infant birth weights, weakened immune system, cancer, and thyroid hormone disruption.; Many PFAS-treated consumer goods are eventually disposed as municipal solid waste (MSW).  Modern MSW landfills are designed with liners and leachate collection systems, with the specific purpose of managing the waste’s liquid releases (leachate and gas condensate) and gaseous emissions (landfill gas). Some discarded PFAS-containing products may instead be sent to industrial Resource Conservation and Recovery Act (RCRA) non-hazardous or construction and demolition landfills, which have - variable designs based on individual state requirements. The fate and transport of PFAS in different types of landfills can be complex and more research is needed to better understand these processes.; As a companion to the recent national priority research Request for Applications (RFA) titled, “National Priorities: Per- and Poly-fluoroalkyl Substances”, the U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results (STAR) program, is seeking applications proposing research that will lead to: (1) better understanding and characterization of the types and quantities of current and historical per- and poly-fluoroalkyl substances (PFAS) and PFAS-containing waste associated with waste disposal (e.g., landfills), as well as media containing PFAS released from these activities (e.g., PFAS in leachate collected by landfills or PFAS leaching to subsurface soils and groundwater); (2) increased knowledge of the fate, transport, potential for degradation or other changes to PFAS, and their mobility during materials management (e.g., under different landfill conditions such as pH, temperature, moisture content) that facilitate or retard such transformation or movement; and (3) new or improved methods that are more effective, efficient (in cost, energy, etc.), and practical in controlling, treating, destroying, or removing PFAS in waste and wastewater, landfill leachates, biosolids, or environmental media. The main goal is to promote innovation in evaluating and managing PFAS in solid waste, landfills, and environmental media that will lead to improved decision making, management practices, and technical methods to minimize the risks to both humans and ecosystems.; The STAR Program's goal is to stimulate and support scientific and engineering research that advances EPA's mission to protect human health and the environment. It is a competitive, peer-reviewed, extramural research program that provides access to the nation's best scientists and engineers in academic and other nonprofit research institutions. STAR funds research on the environmental and public health effects of air quality, environmental changes, water quality and quantity, hazardous waste, toxic substances, and pesticides.

 

 

[NTW] [RESEARCH RESOURCES INFORMATION SESSION]
The ABCs of NIH Grants and Columbia Grant Preparation Boot Camp

Sponsor: Research Resources

Deadline(s): Thursday September 27, 2018 (09/27/2018) from 12:00 PM – 1:30 PM in Hess Student Commons

Contact: To RSVP, please email Craig Kandell at ckk7@columbia.edu

Link(s): https://www.mailman.columbia.edu/public-health-now/events/abcs-nih-grants-and-columbia-grant-preparation-boot-camp

Additional Information: Please join Research Resources on Thursday September 27, 2018 (09/27/2018) from 12:00 PM – 1:30 PM in Hess Student Commons for a talk with Dr. Pam Factor-Litvak, Professor of Epidemiology at CUMC and Associate Dean for Research Resources at the Mailman School who will present “The ABCs of NIH Grants and Columbia Grant Preparation Boot Camp”. Time will be allocated for questions and answers. This event is sponsored by the Mailman School Research Resources (R2) Office. All in the Columbia Community are welcome to attend. To RSVP, please email Craig Kandell at ckk7@columbia.edu

                                                                                                                                                                                                                                        

 

[NTW] [RESEARCH RESOURCES INFORMATION SESSION]
Writing Superior, Clear and Innovative Specific Aims Workshop

Sponsor: Research Resources

Deadline(s): Tuesday October 16, 2018, 3:30 PM – 5:00 PM; Hess Student Commons; 10/16/2018

Contact: To RSVP, please email Craig Kandell at ckk7@columbia.edu

Link(s): https://www.mailman.columbia.edu/public-health-now/events/writing-superior-clear-and-innovative-specific-aims-workshop-1

Additional Information: Please join Research Resources on Tuesday October 16, 2018 (10/16/2018) from 3:30 PM – 5:00 PM in Hess Student Commons for a Writing Superior, Clear and Innovative Specific Aims Workshop, moderated by Dr. Pam Factor-Litvak, Associate Dean for Research Resources at the Mailman School and Professor of Epidemiology at CUMC. All in the Columbia Community are welcome and encouraged to submit draft Specific Aims in advance of the Workshop, as we will discuss and edit the aims during the event. To RSVP, please email Craig Kandell at ckk7@columbia.edu

                                                                                                                                                                                                                                        

 

 

[NTW] [ASPPH WEEKLY NEWSLETTER]

ASPPH WEEKLY NEWSLETTER, 08/17/18

Sponsor:  http://aspph.org

Deadline(s): NA

Contact: submissions@aspph.org; ASPPH 1900 m Street NW, Suite 710 Washington, DC 20036;

Link(s): http://aspph.cmail19.com/t/ViewEmail/d/B634E9EDE73C7B032540EF23F30FEDED/772572174F2D0C57C5EC08CADFFC107B

 

 

 

[NTW] [STANDARD DUE DATES]

Standard Due Dates

https://grants.nih.gov/grants/how-to-apply-application-guide/due-dates-and-submission-policies/due-dates.htm